Heiko Enderling is a German-American mathematical biologist and mathematical oncologist whose research topics include radiotherapy, tumor-immune interactions, cancer stem cells, and dynamic biomarkers.
[1] Enderling graduated from Otto von Guericke University Magdeburg with a degree in Computervisualistik in 2003,[2] and completed his PhD at the University of Dundee in 2006.
His dissertation, Mathematical modelling of breast tumour development, treatment and recurrence, was jointly supervised by Mark Chaplain, Glenn Rowe, and Alexander Anderson.
At Moffitt, he directs a research group on Quantitative Personalized Oncology,[3] with the goal to integrate quantitative modeling into oncology decision making.
His most cited papers are: Enderling was named a Centennial Postdoctoral Fellow of the American Association for Cancer Research in 2008,[4] and Fellow of the Society for Mathematical Biology in 2021.